0210 ecp bighat
BioCentury & Getty Images

Emerging Company Profile

BigHat: AI for antibody optimization beyond target engagement

Emerging Company Profile: $19M a16z-led round to support antibody optimization platform

BigHat debuts with a $19 million a16z-led A round and a platform combining machine learning with lab assays to rapidly engineer antibodies with optimal biophysical and functional properties.

Feb 11, 2021 | 1:31 AM GMT

Read the full 596 word article

How to gain access

Continue reading with a
two-week free trial.